BioMimetix JV, LLC
- Biotech or pharma, therapeutic R&D
BioMimetix is a late-stage clinical company developing novel oncology therapeutics. The company has received FDA Breakthrough Therapy designation and demonstrated positive phase 1/2 data in high-grade glioma, head and neck, and anal & rectal cancer.